论文部分内容阅读
子宫肌瘤是女性最常见的肿瘤 ,占生殖器肿瘤之首。当今治疗子宫肌瘤的建议用药为促性腺激素释放激素激动剂 (ＧｎＲＨａ)和米非司酮 (Ｒｕ4 86 )。米非司酮相对ＧｎＲＨａ而言 ,因其价格低、副作用轻、用药方便、重复性好、具有疗效而应用较广。目前对米非司酮治疗子宫肌瘤的作
Uterine fibroids are the most common tumors in women, accounting for the first genital tumors. The current treatments for uterine fibroids are gonadotropin-releasing hormone agonists (GnRHa) and mifepristone (Ru4 86). Mifepristone relative to GnRHa, because of its low prices, side effects of light, convenient medication, good repeatability, with a curative effect and wider application. The current treatment of uterine fibroids for mifepristone